-
Teva Pharmaceuticals USA, Inc. et al v. Doctor Reddy's Laboratories Ltd. et al DC CAFC
- 1:15-cv-00306
- D. Del.
- Judge: Gregory M. Sleet
- Filed: 04/10/2015
- Closed: 01/31/2017
- Latest Docket Entry: 01/31/2017
- PACER
- Docket updated daily
4
Plaintiffs
12
Defendants
1
Accused
Product
1
Patent-in-Suit
663
Days in
Litigation
-
Teva Pharmaceuticals USA, Inc. et al v. Doctor Reddy's Laboratories Ltd. et al DC CAFC
- 1:15-cv-00306
- D. Del.
- Judge: Gregory M. Sleet
- Filed: 04/10/2015
- Closed: 01/31/2017
- Latest Docket Entry: 01/31/2017
- PACER
- Docket updated daily
Causes of Action
Infringement
Willful Patent Infringement
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
Claim # | Claim Text | Outcome |
---|---|---|
1 |
A method of treatment of a human patient suffering from a relapsing form of multiple sclerosis comprising administration to the human patient of three subcutaneous injections of a 40 mg/ml dose of glatiramer acetate per week so as to treat the human
view more
|
Invalid (103)
Entry 11 |
10 |
A method of treatment of a human patient suffering from a relapsing form of multiple sclerosis comprising subcutaneous injection by the human patient of a 40 mg/ml dose of glatiramer acetate three times per week with at least one day between every
view more
|
Invalid (103)
Entry 11 |
11 |
The method of claim 10, wherein each subcutaneous injection is on day 1, day 3 and day 5; day 1, day 3 and day 6; day 1, day 4 and day 6; day 2, day 4 and day 6; day 2, day 4 and day 7; 2, day 5 and day 7; or day 3, day 5 and day 7 every week.
|
Invalid (103)
Entry 11 |